Cargando…
High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas
World Health Organization grade IV diffuse gliomas, known as glioblastomas, are the most common malignant brain tumors, and they show poor prognosis. Multimodal treatment of surgery followed by radiation and chemotherapy is not sufficient to increase patient survival, which is 12 to 18 months after...
Autores principales: | Jovčevska, Ivana, Zottel, Alja, Šamec, Neja, Mlakar, Jernej, Sorokin, Maxim, Nikitin, Daniil, Buzdin, Anton A., Komel, Radovan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721429/ https://www.ncbi.nlm.nih.gov/pubmed/31357584 http://dx.doi.org/10.3390/cancers11081060 |
Ejemplares similares
-
Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates
por: Vidak, Marko, et al.
Publicado: (2018) -
Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
por: Zottel, Alja, et al.
Publicado: (2020) -
Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
por: Zottel, Alja, et al.
Publicado: (2020) -
Non-animal glioblastoma models for personalized treatment
por: Zottel, Alja, et al.
Publicado: (2023) -
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma
por: Sorokin, Maxim, et al.
Publicado: (2021)